Real-time US stock event calendar and catalyst tracking for understanding upcoming market-moving announcements. Our event calendar helps you prepare for earnings releases, product launches, and other important dates.
Charles River Laboratories (CRL) has experienced notable selling pressure in recent trading sessions, with shares declining 4.45% to trade near $152.04. The drop comes amid elevated volume, suggesting heightened investor activity as the stock tests levels below its recent resistance zone near $159.6
Charles River (CRL) Stock: Down -4.45%, Support Test at $144.44 2026-05-15 - IPO Watch
CRL - Stock Analysis
3406 Comments
1561 Likes
1
Vegas
Daily Reader
2 hours ago
Ah, this slipped by me! 😔
👍 90
Reply
2
Mcguire
Legendary User
5 hours ago
I read this and now I need a minute.
👍 187
Reply
3
Berlene
Registered User
1 day ago
Too late for me… oof. 😅
👍 78
Reply
4
Saban
Power User
1 day ago
Free US stock insider buying and selling tracking with regulatory filing analysis for inside information on company health and management confidence. We monitor corporate insider transactions because company officers often have the best understanding of their business prospects and future outlook. We provide 13D filings, insider buying and selling data, and trend analysis for comprehensive coverage. Get inside information with our comprehensive insider tracking and analysis tools for informed investment decisions.
👍 289
Reply
5
Evelena
Regular Reader
2 days ago
Investors are adapting to new information, resulting in choppy intraday price action.
👍 292
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.